Company / Income Tax
Abbott Laboratories Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$1.9B
FY2025
5-year range
-$6.4B / $1.9B
FY2021-FY2025
Trend
+130.4%
vs FY2024
Sector context
#2 of 162
Health Care
What the data says
Among 162 Health Care companies, Abbott Laboratories is in the bottom 1% for income tax. Income Tax has fluctuated over the past 10 years, ranging from -$6.4B in FY2024 to $1.9B in FY2025.
Based on SEC 10-K filings.
$1.9B in FY2025 with a 5-year CAGR of +29.2%. Ranks 2nd among 162 companies in Health Care.
Increased from $1.1B to $1.9B over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +57.5%
- 5-Year CAGR
- +29.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 162This company $1.9B Sector average $145.4M
▼
+1235.6% above sector average
Key checks
Key Insights
- 5-year CAGR of +29.2%, indicating consistent growth.
- In FY2025, income tax increased 130.4% year-over-year.
- Ranks #2 out of 162 companies in the Health Care sector.
- Lowest income tax in the period was in FY2024.
Company context
Key Data Points
- Strong profit margin: 31.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 27.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.9B | +130.4% |
| FY2024 | -$6.4B | -660.4% |
| FY2023 | $1.1B | +129.4% |
| FY2022 | $497.0M | +27.4% |
| FY2021 | $390.0M | -27.6% |
| FY2020 | $539.0M | +38.2% |
| FY2019 | $390.0M | +11.4% |
| FY2018 | $350.0M | -39.3% |
| FY2017 | $577.0M | -27.6% |
| FY2016 | $797.0M | +1403.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026